ENVERIC BIOSCIENCES, INC. Cash and Restricted Cash
ENVERIC BIOSCIENCES, INC. (ENVB) had Cash and Restricted Cash of $1.58 million as of 2020-12-31, per its 10-K filed 2021-04-01.
Discontinued › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2021-04-01
- 2020-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.58M.
- 2020-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.84M.
- 2020-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.09M.
- 2020-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1.27M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2020-12-31 | $1.58M 10-K · filed 2021-04-01 | |
| 2020-09-30 | $2.84M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $2.09M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $1.27M 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $43.71K 10-K · filed 2021-04-01 | $431.40K 10-K · filed 2020-03-25 |
| 2019-09-30 | $1.60M 10-Q · filed 2020-11-16 | $499.69K 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.60M 10-Q · filed 2020-08-14 | |
| 2019-03-31 | $1.72M 10-Q · filed 2020-05-15 | |
| 2018-12-31 | $113.67K 10-K · filed 2021-04-01 | $1.37M 10-Q · filed 2019-05-14 |
| 2018-09-30 | $2.06M 10-Q · filed 2019-11-08 | |
| 2018-06-30 | $915.11K 10-Q · filed 2019-08-14 | |
| 2018-03-31 | $1.76M 10-Q · filed 2019-05-14 | |
| 2017-12-31 | $4.88M 10-K/A · filed 2020-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |